Profilo
Christophe Bancel is the founder of iBionext SAS, founded in 2012, serving as Venture Partner since 2012.
Mr. Bancel is the founder of Tissium SA, founded in 2013, serving as Chief Executive Officer & Director since 2013.
Former job includes Director at BrainEver SAS.
Posizioni attive di Christophe Bancel
| Società | Posizione | Inizio |
|---|---|---|
Tissium SA
Tissium SA BiotechnologyHealth Technology Develops biomorphic and programmable polymers for tissue reconstruction | Fondatore | 01/01/2013 |
iBionext SAS
iBionext SAS Investment ManagersFinance iBionext is an active manager invests in young companies located in France. The firm targets companies operating in the health technology (biotech/medtech/e-health). They provide equity financing for seed, later and growth capital requirements. | Fondatore | 01/10/2012 |
Precedenti posizioni note di Christophe Bancel
| Società | Posizione | Fine |
|---|---|---|
Brainever SAS
Brainever SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel therapies for patients | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Tissium SA
Tissium SA BiotechnologyHealth Technology Develops biomorphic and programmable polymers for tissue reconstruction | Health Technology |
iBionext SAS
iBionext SAS Investment ManagersFinance iBionext is an active manager invests in young companies located in France. The firm targets companies operating in the health technology (biotech/medtech/e-health). They provide equity financing for seed, later and growth capital requirements. | Finance |
Brainever SAS
Brainever SAS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel therapies for patients | Health Technology |
















